These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9316525)

  • 1. Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study.
    Kontny F; Dale J; Abildgaard U; Pedersen TR
    J Am Coll Cardiol; 1997 Oct; 30(4):962-9. PubMed ID: 9316525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular thrombosis and arterial embolism after thrombolysis in acute anterior myocardial infarction: predictors and effects of adjunctive antithrombotic therapy.
    Kontny F; Dale J; Hegrenaes L; Lem P; Søberg T; Morstøl T
    Eur Heart J; 1993 Nov; 14(11):1489-92. PubMed ID: 8299630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
    Klein W; Buchwald A; Hillis SE; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Circulation; 1997 Jul; 96(1):61-8. PubMed ID: 9236418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction.
    Kakkar VV; Iyengar SS; De Lorenzo F; Hargreaves JR; Kadziola ZA;
    Indian Heart J; 2000; 52(5):533-9. PubMed ID: 11256775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in left ventricular thrombosis and systemic embolism.
    Cregler LL
    Am Heart J; 1992 Apr; 123(4 Pt 2):1110-4. PubMed ID: 1553880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of thrombolytic therapy on the incidence of left ventricular thrombi after acute anterior myocardial infarction: role of successful reperfusion.
    Ileri M; Tandoğan I; Koşar F; Yetkin E; Büyükaşik Y; Kütük E
    Clin Cardiol; 1999 Jul; 22(7):477-80. PubMed ID: 10410292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular mural thrombus after acute myocardial infarction.
    Keeley EC; Hillis LD
    Clin Cardiol; 1996 Feb; 19(2):83-6. PubMed ID: 8821415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
    Frostfeldt G; Ahlberg G; Gustafsson G; Helmius G; Lindahl B; Nygren A; Siegbahn A; Swahn E; Venge P; Wallentin L
    J Am Coll Cardiol; 1999 Mar; 33(3):627-33. PubMed ID: 10080461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.
    Rubboli A; Ottani F; Capecchi A; Brancaleoni R; Galvani M; Swahn E
    Cardiology; 2007; 107(2):132-9. PubMed ID: 16864962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis.
    Vaitkus PT; Barnathan ES
    J Am Coll Cardiol; 1993 Oct; 22(4):1004-9. PubMed ID: 8409034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.
    Wallentin L; Bergstrand L; Dellborg M; Fellenius C; Granger CB; Lindahl B; Lins LE; Nilsson T; Pehrsson K; Siegbahn A; Swahn E
    Eur Heart J; 2003 May; 24(10):897-908. PubMed ID: 12714021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolic potential of left ventricular thrombus after myocardial infarction: a two-dimensional echocardiographic study of 119 patients.
    Visser CA; Kan G; Meltzer RS; Dunning AJ; Roelandt J
    J Am Coll Cardiol; 1985 Jun; 5(6):1276-80. PubMed ID: 3998310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prospective assessment of left ventricular thrombus in anterior wall acute myocardial infarction and implications for a rational approach to embolic risk.
    Domenicucci S; Chiarella F; Bellotti P; Bellone P; Lupi G; Vecchio C
    Am J Cardiol; 1999 Feb; 83(4):519-24. PubMed ID: 10073854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postinfarction ventricular thrombus and embolic risk: epidemiological data in the thrombolytic era.
    López-Sendón J; López de Sá E; Delcán JL
    G Ital Cardiol; 1994 Mar; 24(3):239-44. PubMed ID: 8063058
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective two-dimensional echocardiographic evaluation of left ventricular thrombus and embolism after acute myocardial infarction.
    Jugdutt BI; Sivaram CA
    J Am Coll Cardiol; 1989 Mar; 13(3):554-64. PubMed ID: 2918160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of left ventricular thrombus in myocardial infarction: a rationale in support of masterly inactivity.
    Nihoyannopoulos P; Smith GC; Maseri A; Foale RA
    J Am Coll Cardiol; 1989 Oct; 14(4):903-11. PubMed ID: 2794276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment.
    McCarthy CP; Vaduganathan M; McCarthy KJ; Januzzi JL; Bhatt DL; McEvoy JW
    JAMA Cardiol; 2018 Jul; 3(7):642-649. PubMed ID: 29800958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: the ASSENT PLUS study.
    Wallentin L; Dellborg DM; Lindahl B; Nilsson T; Pehrsson K; Swahn E
    Clin Cardiol; 2001 Mar; 24(3 Suppl):I12-4. PubMed ID: 11286309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.